HCV-1b Intra-Subtype Variability: Impact on Genetic Barrier to Protease Inhibitors

Infection, Genetics and Evolution - Netherlands
doi 10.1016/j.meegid.2014.01.028
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Naturally Occurring Mutations to HCV Protease Inhibitors in Treatment-Naïve Patients

Virology Journal
VirologyInfectious Diseases
2012English

NS3 Protease Polymorphism and Natural Resistance to Protease Inhibitors in French Patients Infected With HCV Genotypes 1–5

Antiviral Therapy
Infectious DiseasesPharmacology
2011English

Physical Properties and Biological Activity of Some Novel HCV NS3 Protease Inhibitors

Egyptian Journal of Physics
2018English

Synergy of a Hepatitis C Virus (HCV) NS4A Antagonist in Combination With HCV Protease and Polymerase Inhibitors

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

Genetic Barrier to Direct Acting Antivirals in HCV Sequences Deposited in the European Databank

PLoS ONE
Multidisciplinary
2016English

Computational Study of the Resistance Shown by the Subtype B/Hiv-1 Protease to Currently Known Inhibitors

Biochemistry
Biochemistry
2010English

HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b

BMC Gastroenterology
MedicineGastroenterology
2012English

Genetic Variability in Cysteine Protease Genes of Haemonchus Contortus

Parasitology
Animal ScienceZoologyParasitologyInfectious Diseases
2004English

Protease Inhibitors

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy